Safety

Zioptan (tafluprost) ophthalmic solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

September 2015

Summary View

ADVERSE REACTIONS

Postmarketing Experience
  • Respiratory disorders: exacerbation of asthma, dyspnea

PATIENT INFORMATION

What are the possible side effects of Zioptan

…Additionally, the following side effects have been reported in general use:

  • worsening of asthma
  • shortness of breath

 

February 2013

Summary View 

ADVERSE REACTION

Postmarketing Experience
  • uveitis and iritis

 

Page Last Updated: 10/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English